phase 2 study lymphoproliferative disorders: results of a prospective multicenter Efficacy and safety of rituximab in B-cell post-transplantation
暂无分享，去创建一个
G. Salles | A. Fischer | É. Oksenhendler | L. Chatenoud | A. Moreau | V. Leblond | P. Lang | O. Hermine | R. Herbrecht | N. Milpied | F. Morschhauser | A. Ferrant | A. Jaccard | P. Morand | A. Stoppa | N. Berriot-Varoqueaux | Etienne Sylvain Choquet